Nasopharyngeal non-keratinizing carcinoma is a common type of nasopharyngeal carcinoma, which may be related to EBV infection, heredity or environmental factors. Clinical manifestations of nasopharyngeal non-keratinizing carcinoma include aspirated bloody mucus, nasal congestion, tinnitus, facial numbness, etc. According to the different stages of the disease, patients are given various treatments, such as radical radiotherapy, surgery, chemotherapy and targeted treatment, and early stage patients are given a good prognosis, while late stage patients are given a poorer prognosis. According to the latest WHO standard, nasopharyngeal cancer can be divided into non-keratinizing squamous carcinoma, keratinizing squamous carcinoma, basal cell-like squamous carcinoma, papillary adenocarcinoma and so on, among which non-keratinizing squamous carcinoma can be divided into differentiated and undifferentiated types, and non-keratinizing carcinoma accounts for the majority of nasopharyngeal cancers in China. Clinical symptoms of nasopharyngeal non-keratinizing carcinoma include bloody nasal discharge, nasal congestion, hearing loss, tinnitus, facial numbness, enlarged cervical lymph nodes, etc. Treatment methods include radiotherapy, surgery, systemic chemotherapy and targeted therapy.